National use of thrombolysis with alteplase for acute ischaemic stroke via telemedicine in Denmark: a model of budgetary impact and cost effectiveness.
Lars Ehlers; Wilhelmina Maria Müskens; Lotte Groth Jensen; Mette Kjølby; Grethe Andersen
The purpose of this analysis was to assess the budgetary impact and cost effectiveness of the national use of thrombolysis with alteplase (recombinant tissue plasminogen activator; rt-PA) for acute ischaemic stroke via telemedicine in Denmark.
National use of thrombolysis with alteplase for acute ischemic stroke via telemedicine in Denmark
Udgivelsesform | Videnskabelige artikler |
År | 2008 |
Udgiver | CNS Drugs 2008;22(1):73-81. |